Literature DB >> 26926640

Fluoroquinolone and Third-Generation-Cephalosporin Resistance among Hospitalized Patients with Urinary Tract Infections Due to Escherichia coli: Do Rates Vary by Hospital Characteristics and Geographic Region?

Monique R Bidell1, Melissa Palchak2, John Mohr2, Thomas P Lodise3.   

Abstract

This analysis of nearly 10,000 hospital-associated urinary tract infection (UTI) episodes due to Escherichia coli showed that fluoroquinolone and third-generation-cephalosporin resistance rates were 34.5% and 8.6%, respectively; the rate of concurrent resistance to both agents was 7.3%. Fluoroquinolone resistance rates exceeded 25% regardless of geographic location or hospital characteristics. The findings suggest that fluoroquinolones should be reserved and third-generation cephalosporins be used with caution as empirical agents for hospitalized patients with UTIs due to E. coli.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26926640      PMCID： PMC4862467          DOI： 10.1128/AAC.02505-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  6 in total

Review 1.  Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria.

Authors:  Ann Pallett; Kieran Hand
Journal:  J Antimicrob Chemother       Date:  2010-11       Impact factor: 5.790

Review 2.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Authors:  Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

3.  Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011.

Authors:  Sam K Bouchillon; Robert E Badal; Daryl J Hoban; Stephen P Hawser
Journal:  Clin Ther       Date:  2013-04-25       Impact factor: 3.393

4.  Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America.

Authors:  Thomas M Hooton; Suzanne F Bradley; Diana D Cardenas; Richard Colgan; Suzanne E Geerlings; James C Rice; Sanjay Saint; Anthony J Schaeffer; Paul A Tambayh; Peter Tenke; Lindsay E Nicolle
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

5.  Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America).

Authors:  D Mathai; R N Jones; M A Pfaller
Journal:  Diagn Microbiol Infect Dis       Date:  2001-07       Impact factor: 2.803

6.  Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000).

Authors:  Kelley A Gordon; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2003-04       Impact factor: 2.803
  6 in total
  20 in total

1.  Antimicrobial Resistance of Escherichia coli Urinary Isolates in the Veterans Affairs Health Care System.

Authors:  Haley J Morrill; Jacob B Morton; Aisling R Caffrey; Lan Jiang; David Dosa; Leonard A Mermel; Kerry L LaPlante
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

2.  The impact of antimicrobial stewardship program implementation at four tertiary private hospitals: results of a five-years pre-post analysis.

Authors:  Awad Al-Omari; Abbas Al Mutair; Saad Alhumaid; Samer Salih; Ahmed Alanazi; Hesham Albarsan; Maha Abourayan; Maha Al Subaie
Journal:  Antimicrob Resist Infect Control       Date:  2020-06-29       Impact factor: 4.887

3.  Antimicrobial Susceptibility and Cross-Resistance Patterns among Common Complicated Urinary Tract Infections in U.S. Hospitals, 2013 to 2018.

Authors:  Marya D Zilberberg; Brian H Nathanson; Kate Sulham; Andrew F Shorr
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

4.  Antimicrobial resistance prevalence, rates of hospitalization with septicemia and rates of mortality with sepsis in adults in different US states.

Authors:  Edward Goldstein; Derek R MacFadden; Zeynal Karaca; Claudia A Steiner; Cecile Viboud; Marc Lipsitch
Journal:  Int J Antimicrob Agents       Date:  2019-03-06       Impact factor: 5.283

5.  Antibiotic Multidrug Resistance of Escherichia coli Causing Device- and Procedure-related Infections in the United States Reported to the National Healthcare Safety Network, 2013-2017.

Authors:  Athena P Kourtis; Edward A Sheriff; Lindsey M Weiner-Lastinger; Kim Elmore; Leigh Ellyn Preston; Margaret Dudeck; L Clifford McDonald
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 20.999

6.  A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.

Authors:  Pau Bosch-Nicolau; Vicenç Falcó; Belén Viñado; Antonia Andreu; Oscar Len; Benito Almirante; Carles Pigrau
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

7.  The impact of antimicrobial stewardship program implementation at four tertiary private hospitals: results of a five-years pre-post analysis.

Authors:  Awad Al-Omari; Abbas Al Mutair; Saad Alhumaid; Samer Salih; Ahmed Alanazi; Hesham Albarsan; Maha Abourayan; Maha Al Subaie
Journal:  Antimicrob Resist Infect Control       Date:  2020-06-29       Impact factor: 4.887

8.  Study of class 1 integrons in multidrug-resistant uropathogenic Escherichia coli isolated from different hospitals in Karachi.

Authors:  Fouzia Zeeshan Khan; Tehseen Nawaz; Zulfiqar Ali Mirani; Saeed Khan; Yasir Raza; Shahana Urooj Kazmi
Journal:  Iran J Basic Med Sci       Date:  2018-10       Impact factor: 2.699

9.  Prevalence of quinolone-resistant uropathogenic Escherichia coli in a tertiary care hospital in south Iran.

Authors:  Yalda Malekzadegan; Elham Rastegar; Melika Moradi; Hamid Heidari; Hadi Sedigh Ebrahim-Saraie
Journal:  Infect Drug Resist       Date:  2019-06-19       Impact factor: 4.003

10.  Levels of outpatient prescribing for four major antibiotic classes and rates of septicemia hospitalization in adults in different US states - a statistical analysis.

Authors:  Edward Goldstein; Scott W Olesen; Zeynal Karaca; Claudia A Steiner; Cecile Viboud; Marc Lipsitch
Journal:  BMC Public Health       Date:  2019-08-19       Impact factor: 3.295
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.